Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T88015 | Target Info | |||
Target Name | COVID-19 3C-like protease (3CLpro) | ||||
Synonyms | COVID-19 3CL-PRO; COVID-19 3CLp; COVID-19 nsp5 | ||||
Gene Name | COVID-19 rep | ||||
Biochemical Class | Coronaviruses polyprotein 1ab family | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | N-[(2S)-1-[[(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | Ligand Info | |||
Canonical SMILES | CC(C)CC(C(=O)NC(CC1CCNC1=O)C(C2=NC3=CC=CC=C3S2)O)NC(=O)C4=CC5=C(N4)C=CC=C5OC | ||||
InChI | 1S/C30H35N5O5S/c1-16(2)13-22(34-29(39)23-15-18-19(32-23)8-6-9-24(18)40-3)28(38)33-21(14-17-11-12-31-27(17)37)26(36)30-35-20-7-4-5-10-25(20)41-30/h4-10,15-17,21-22,26,32,36H,11-14H2,1-3H3,(H,31,37)(H,33,38)(H,34,39)/t17-,21-,22-,26-/m0/s1 | ||||
InChIKey | DHQWCSDZTRDSRP-XIBGDNMGSA-N | ||||
PubChem Compound ID | 154573806 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7JKV Crystal Structure of SARS-CoV-2 main protease in complex with an inhibitor GRL-2420 | ||||||
Method | X-ray diffraction | Resolution | 1.25 Å | Mutation | No | [1] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSCGSVGF150 NIDYDCVSFC 160 YMHHMELPTG170 VHAGTDLEGN180 FYGPFVDRQT190 AQAAGTDTTI200 TVNVLAWLYA 210 AVINGDRWFL220 NRFTTTLNDF230 NLVAMKYNYE240 PLTQDHVDIL250 GPLSAQTGIA 260 VLDMCASLKE270 LLQNGMNGRT280 ILGSALLEDE290 FTPFDVVRQC300 S |
|||||
|
THR25
3.504
LEU27
4.102
HIS41
3.102
VAL42
4.750
CYS44
4.307
MET49
3.520
TYR54
4.646
PHE140
3.141
LEU141
3.672
ASN142
3.186
GLY143
3.421
SER144
3.416
CYS145
1.865
|
|||||
PDB ID: 6XR3 X-ray Structure of SARS-CoV-2 main protease bound to GRL-024-20 at 1.45 A | ||||||
Method | X-ray diffraction | Resolution | 1.45 Å | Mutation | No | [2] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSCGSVGF150 NIDYDCVSFC 160 YMHHMELPTG170 VHAGTDLEGN180 FYGPFVDRQT190 AQAAGTDTTI200 TVNVLAWLYA 210 AVINGDRWFL220 NRFTTTLNDF230 NLVAMKYNYE240 PLTQDHVDIL250 GPLSAQTGIA 260 VLDMCASLKE270 LLQNGMNGRT280 ILGSALLEDE290 FTPFDVVRQC300 SGVTF |
|||||
|
THR25
2.698
LEU27
3.314
PRO39
4.733
HIS41
2.559
VAL42
3.598
CYS44
3.090
MET49
3.012
LEU50
4.737
PRO52
4.986
TYR54
3.811
PHE140
2.948
LEU141
3.371
ASN142
2.275
GLY143
2.740
SER144
2.660
CYS145
1.763
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A small molecule?compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat Commun. 2021 Jan 28;12(1):668. | ||||
REF 2 | X-ray Structure of SARS-CoV-2 main protease bound to GRL-024-20 at 1.45 A |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.